Merck (NYSE:MRK | MRK Price Prediction) is the second big drugmaker to reward investors with an earnings beat and a raised ...
12d
Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy.
Wise investors, however, will view this pullback from J&J shares as an opportunity rather than an omen. Although the company ...
Johnson & Johnson has been dealing for years with thousands of lawsuits related to its talc-based products, which plaintiffs claim gave them cancer. This issue has somewhat affected the drugmaker's ...
Johnson & Johnson (NYSE: JNJ) reported new oncology data, including a 75% tumor response rate for JNJ-6143 in advanced ...
Investors are paying a premium for Johnson & Johnson (JNJ) stock. It trades at 29.2 times earnings, compared to 22.9 for the ...
Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer on Thursday told investors why he thinks the stock of Johnson & Johnson is performing well this year even as the broader healthcare sector lags.
Today, Johnson & Johnson released its financial results for Q3 2025, which once again stunned Wall Street. So, sales of Rybrevant/Lazcluze, the 'diamond' in its oncology franchise, reached $198 ...
Monday - Friday, 6:00 - 7:00 PM ET As Wall Street navigates a jam-packed start to earnings season, CNBC's Jim Cramer explained what made shares of Johnson & Johnson rise after the company posted its ...
Johnson & Johnson (NYSE:JNJ) reported 48-week results from its Phase 3 FUZION study evaluating Tremfya (guselkumab) in adults with Crohn’s disease and active perianal fistulas, showing that fistula ...
Johnson & Johnson will spend $2 billion over the next 10 years renting a 160,000-square-foot facility at Fujifilm Diosynth's massive manufacturing complex in Holly Springs, N.C. ((Photo by Cristina ...
Add Yahoo as a preferred source to see more of our stories on Google. On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked ...
Johnson & Johnson claims a former associate director now employed by Summit Therapeutics downloaded more than 7,000 confidential internal documents to her personal device before and after her ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results